Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.

El-Dakdouki MH, Xia J, Zhu DC, Kavunja H, Grieshaber J, O'Reilly S, McCormick JJ, Huang X.

ACS Appl Mater Interfaces. 2014 Jan 8;6(1):697-705. doi: 10.1021/am404946v. Epub 2013 Dec 12.

PMID:
24308364
[PubMed - indexed for MEDLINE]
2.

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.

Cho HJ, Yoon IS, Yoon HY, Koo H, Jin YJ, Ko SH, Shim JS, Kim K, Kwon IC, Kim DD.

Biomaterials. 2012 Feb;33(4):1190-200. doi: 10.1016/j.biomaterials.2011.10.064. Epub 2011 Nov 9.

PMID:
22074664
[PubMed - indexed for MEDLINE]
3.

Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.

El-Dakdouki MH, Zhu DC, El-Boubbou K, Kamat M, Chen J, Li W, Huang X.

Biomacromolecules. 2012 Apr 9;13(4):1144-51. doi: 10.1021/bm300046h. Epub 2012 Mar 13.

PMID:
22372739
[PubMed - indexed for MEDLINE]
4.

Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery.

Chen J, Shi M, Liu P, Ko A, Zhong W, Liao W, Xing MM.

Biomaterials. 2014 Jan;35(4):1240-8. doi: 10.1016/j.biomaterials.2013.10.057. Epub 2013 Nov 14.

PMID:
24239110
[PubMed - indexed for MEDLINE]
5.

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.

Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD.

J Control Release. 2014 Jan 28;174:98-108. doi: 10.1016/j.jconrel.2013.11.016. Epub 2013 Nov 23.

PMID:
24280260
[PubMed - indexed for MEDLINE]
6.

Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.

Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17.

PMID:
23958784
[PubMed - indexed for MEDLINE]
7.

Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.

Jin YJ, Termsarasab U, Ko SH, Shim JS, Chong S, Chung SJ, Shim CK, Cho HJ, Kim DD.

Pharm Res. 2012 Dec;29(12):3443-54. doi: 10.1007/s11095-012-0839-9. Epub 2012 Aug 11.

PMID:
22886625
[PubMed - indexed for MEDLINE]
8.

Cucumber mosaic virus as drug delivery vehicle for doxorubicin.

Zeng Q, Wen H, Wen Q, Chen X, Wang Y, Xuan W, Liang J, Wan S.

Biomaterials. 2013 Jun;34(19):4632-42. doi: 10.1016/j.biomaterials.2013.03.017. Epub 2013 Mar 23.

PMID:
23528229
[PubMed - indexed for MEDLINE]
9.

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.

Han HS, Lee J, Kim HR, Chae SY, Kim M, Saravanakumar G, Yoon HY, You DG, Ko H, Kim K, Kwon IC, Park JC, Park JH.

J Control Release. 2013 Jun 10;168(2):105-14. doi: 10.1016/j.jconrel.2013.02.022. Epub 2013 Mar 6.

PMID:
23474029
[PubMed - indexed for MEDLINE]
10.

Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.

Maeng JH, Lee DH, Jung KH, Bae YH, Park IS, Jeong S, Jeon YS, Shim CK, Kim W, Kim J, Lee J, Lee YM, Kim JH, Kim WH, Hong SS.

Biomaterials. 2010 Jun;31(18):4995-5006. doi: 10.1016/j.biomaterials.2010.02.068. Epub 2010 Mar 26.

PMID:
20347138
[PubMed - indexed for MEDLINE]
11.

Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.

Auzenne E, Ghosh SC, Khodadadian M, Rivera B, Farquhar D, Price RE, Ravoori M, Kundra V, Freedman RS, Klostergaard J.

Neoplasia. 2007 Jun;9(6):479-86.

PMID:
17603630
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.

Colombo PE, Boustta M, Poujol S, Jarlier M, Bressolle F, Teulon I, Ladjemi MZ, Pinguet F, Rouanet P, Vert M.

Gynecol Oncol. 2011 Sep;122(3):632-40. doi: 10.1016/j.ygyno.2011.05.032. Epub 2011 Jun 12.

PMID:
21665252
[PubMed - indexed for MEDLINE]
13.

Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.

Lee BS, Park K, Park S, Kim GC, Kim HJ, Lee S, Kil H, Oh SJ, Chi D, Kim K, Choi K, Kwon IC, Kim SY.

J Control Release. 2010 Oct 15;147(2):253-60. doi: 10.1016/j.jconrel.2010.07.096. Epub 2010 Jul 16.

PMID:
20624433
[PubMed - indexed for MEDLINE]
14.

Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.

Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.

Nanomedicine. 2007 Dec;3(4):246-57.

PMID:
18068091
[PubMed - indexed for MEDLINE]
15.

Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.

El-Dakdouki MH, Puré E, Huang X.

Nanoscale. 2013 May 7;5(9):3895-903. doi: 10.1039/c3nr33777d. Epub 2013 Mar 26.

PMID:
23529646
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C.

J Control Release. 2012 Mar 10;158(2):319-28. doi: 10.1016/j.jconrel.2011.10.028. Epub 2011 Oct 28.

PMID:
22063003
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.

Yu M, Jambhrunkar S, Thorn P, Chen J, Gu W, Yu C.

Nanoscale. 2013 Jan 7;5(1):178-83. doi: 10.1039/c2nr32145a. Epub 2012 Oct 18.

PMID:
23076766
[PubMed - indexed for MEDLINE]
18.

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.

Pastorino F, Di Paolo D, Piccardi F, Nico B, Ribatti D, Daga A, Baio G, Neumaier CE, Brignole C, Loi M, Marimpietri D, Pagnan G, Cilli M, Lepekhin EA, Garde SV, Longhi R, Corti A, Allen TM, Wu JJ, Ponzoni M.

Clin Cancer Res. 2008 Nov 15;14(22):7320-9. doi: 10.1158/1078-0432.CCR-08-0804.

PMID:
19010847
[PubMed - indexed for MEDLINE]
Free Article
19.

The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice.

Upadhyay KK, Mishra AK, Chuttani K, Kaul A, Schatz C, Le Meins JF, Misra A, Lecommandoux S.

Nanomedicine. 2012 Jan;8(1):71-80. doi: 10.1016/j.nano.2011.05.008. Epub 2011 Jun 22.

PMID:
21703363
[PubMed - indexed for MEDLINE]
20.

The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.

Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC.

Biomaterials. 2012 Aug;33(23):5788-97. doi: 10.1016/j.biomaterials.2012.04.057. Epub 2012 May 15.

PMID:
22591612
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk